These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23867693)

  • 1. Mucocutaneous leishmaniasis: mucosal manifestations in an endemic country.
    de Paulo LF; Rocha GF; Luisi CM; Rosa RR; Durighetto AF
    Int J Infect Dis; 2013 Nov; 17(11):e1088-9. PubMed ID: 23867693
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and Safety of Liposomal Amphotericin B for the Treatment of Mucosal Leishmaniasis from the New World: A Retrospective Study.
    Cunha MA; Leão AC; de Cassia Soler R; Lindoso JA
    Am J Trop Med Hyg; 2015 Dec; 93(6):1214-8. PubMed ID: 26483120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated oral mucosal leishmaniasis.
    Ahmed NH; Mukherjee A; Samantaray JC; Kar HK
    Indian J Dermatol Venereol Leprol; 2014; 80(4):343-5. PubMed ID: 25035365
    [No Abstract]   [Full Text] [Related]  

  • 4. Mucocutaneous leishmaniasis: report of a case with massive involvement of nasal, pharyngeal and laryngeal mucosa.
    Di Lella F; Vincenti V; Zennaro D; Afeltra A; Baldi A; Giordano D; Pasanisi E; Bacciu A; Bacciu S; Di Lella G
    Int J Oral Maxillofac Surg; 2006 Sep; 35(9):870-2. PubMed ID: 16574379
    [No Abstract]   [Full Text] [Related]  

  • 5. Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients.
    Rocio C; Amato VS; Camargo RA; Tuon FF; Nicodemo AC
    Trans R Soc Trop Med Hyg; 2014 Mar; 108(3):176-8. PubMed ID: 24535153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prolonged incubation period in zosteriform Leishmania panamensis.
    Gogol-Tagliaferro A; Swender D; Chernin L; Tcheurekdjian H; Meyerson H; Hostoffer R
    Cutis; 2014 Feb; 93(2):E5-6. PubMed ID: 24605357
    [No Abstract]   [Full Text] [Related]  

  • 7. First molecular-based detection of mucocutaneous leishmaniasis caused by Leishmania major in Iran.
    Alborzi A; Pouladfar GR; Ghadimi Moghadam A; Attar A; Drakhshan N; Khosravi Maharlooei M; Kalantari M
    J Infect Dev Ctries; 2013 May; 7(5):413-6. PubMed ID: 23669431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal leishmaniasis in Brazilian patients: two case reports with similar clinical presentation and different approaches.
    Cruz AF; Resende RG; Albuquerque DR; de Lacerda JC; Leite CF; Ferreira Aguiar MC
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Dec; 122(6):e199-e203. PubMed ID: 27234853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary oral leishmaniasis mimicking oral cancer: a case report.
    Celentano A; Ruoppo E; Mansueto G; Mignogna MD
    Br J Oral Maxillofac Surg; 2015 Apr; 53(4):396-8. PubMed ID: 25701438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal Leishmania infantum infection.
    Richter J; Hanus I; Häussinger D; Löscher T; Harms G
    Parasitol Res; 2011 Sep; 109(3):959-62. PubMed ID: 21499751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucocutaneous leishmaniasis must be included in the differential diagnosis of midline destructive disease: two case reports.
    Crovetto-Martínez R; Aguirre-Urizar JM; Orte-Aldea C; Araluce-Iturbe I; Whyte-Orozco J; Crovetto-De la Torre MA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):e20-6. PubMed ID: 25442251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A patient with chronic labial oedema and nodular palatal lesions.
    Gonzalez-Olivares M; Moreno-Torres A; Navarro-Vidal B; Cordoba S; Garrido-Rios AA; Ruiz-Giardin JM; Borbujo J
    Clin Exp Dermatol; 2018 Jun; 43(4):481-484. PubMed ID: 29344972
    [No Abstract]   [Full Text] [Related]  

  • 13. Mucocutaneous leishmaniasis treated with liposomal amphotericin B.
    Lambertucci JR; Silva LC
    Rev Soc Bras Med Trop; 2008; 41(1):87-8. PubMed ID: 18368279
    [No Abstract]   [Full Text] [Related]  

  • 14. Liposomal amphotericin B treatment of Old World cutaneous and mucosal leishmaniasis: A literature review.
    Mosimann V; Neumayr A; Paris DH; Blum J
    Acta Trop; 2018 Jun; 182():246-250. PubMed ID: 29550282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal leishmaniasis unresponsive to glucantime therapy successfully treated with AmBisome.
    Nonata R; Sampaio R; Marsden PD
    Trans R Soc Trop Med Hyg; 1997; 91(1):77. PubMed ID: 9093636
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of mucosal leishmaniasis (L. infantum) with miltefosine in a patient with Good syndrome.
    Stoeckle M; Holbro A; Arnold A; Neumayr A; Weisser M; Blum J
    Acta Trop; 2013 Oct; 128(1):168-70. PubMed ID: 23871798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American tegumentary leishmaniasis: diagnostic and treatment challenges in a clinical case.
    Oyama J; Ferreira FBP; Conter CC; Lera-Nonose DSSL; Ramos-Milaré ÁCFH; Venazzi EAS; Silveira TGV; Lonardoni MVC
    Rev Inst Med Trop Sao Paulo; 2018; 60():e3. PubMed ID: 29451600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmaniasis of the tongue in a renal transplant recipient.
    Alrajhi AA; Saleem M; Ibrahim EA; Gramiccia M
    Clin Infect Dis; 1998 Nov; 27(5):1332-3. PubMed ID: 9827301
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of mucocutaneous leishmaniasis.
    Virgilio GR; Hale BR
    Otolaryngol Head Neck Surg; 2005 May; 132(5):800-1. PubMed ID: 15886638
    [No Abstract]   [Full Text] [Related]  

  • 20. Atypical mucocutaneous involvement with Leishmania donovani.
    Pulimood SA; Rupali P; Ajjampur SS; Thomas M; Mehrotra S; Sundar S
    Natl Med J India; 2012; 25(3):148-50. PubMed ID: 22963292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.